Storys zum Thema Science

Schweizerischer Nationalfonds / Fonds national suisse

Improving hydropower through long-range drought forecasts

Bern (ots) - Researchers at the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) have developed a complex hydrological model for forecasting dry spells lasting several weeks with high spatial resolution. These predictions make it possible, for example, to operate hydropower plants more profitably. Changing climatic conditions pose extra challenges for hydropower plant operators. As part of the ...

SAKK - Swiss Group for Clinical Cancer Research

The GIST Group Switzerland, the support group for patients with gastrointestinal stromal tumor, has awarded its science prize for the ninth time.

Merck Healthcare Germany

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared ...

Schweizerischer Nationalfonds / Fonds national suisse

SNSF image competition 2019: Participate and share unexpected insights into science

Bern (ots) - Following the success of the first two editions, the Swiss National Science Foundation has decided to stage its competition for images and short videos from the world of science for a third time. The best entries will be showcased in various exhibitions and via social media. The over 800 entries in 2017 and 2018, and the enthusiasm generated among the ...

Schweizerischer Nationalfonds / Fonds national suisse

How to certify a quantum computer

Bern (ots) - SNSF-funded researchers have developed a protocol for checking that quantum computer components function as they should. That's a critical step in making the promise of quantum computing - including unprecedented computing power - a reality. Quantum computers are being developed by teams working not only at universities but also at Google, IBM, Microsoft and D-Wave, a start-up company. And things are evolving quickly, says Nicolas Sangouard, SNSF Professor at ...

Schweizerischer Nationalfonds / Fonds national suisse

Latsis Prize 2018: Andrea Ablasser unlocks the secret of rapid virus defence

Schweizerischer Nationalfonds / Fonds national suisse

Innovations in ultrasound imaging improve breast cancer detection

Bern (ots) - A new ultrasound technique can help distinguish benign breast tumours from malignant ones. The technology was developed with support from the Swiss National Science Foundation. Ultrasound is one of the three main technologies used in medical imaging. It is more compact and affordable than nuclear magnetic resonance imaging (MRI) techniques, and safer than x-rays. But the images it produces are often difficult ...

Schweizerischer Nationalfonds / Fonds national suisse

Research into new audio experience resonates at Tinguely Museum in Basel

Bern (ots) - Research into new audio experience resonates at Tinguely Museum in Basel A project funded by the Swiss National Science Foundation is investigating the audio phenomena and sound culture associated with radio. As part of this work, an algorithm has been developed to search radio archives using sound-based criteria. Visitors to the "Radiophonic Spaces" ...

Schweizerischer Nationalfonds / Fonds national suisse

Tax incentives reduce energy consumption - if effectively implemented

Bern (ots) - By studying the effects of Basel's electricity levy, researchers at the University of Lucerne investigated how tax incentives work in practice and how their impact on energy consumption could be increased. The National Council and the Council of States decided not to debate the proposals of the Federal Council on the second phase of the Energy Strategy ...

Schweizerischer Nationalfonds / Fonds national suisse

Marie Heim-Vögtlin Prize 2018: Sara Montagner discovers the epigenetic secrets of mast cells

Bern (ots) - Epigenetic modifications of our DNA are a key aspect of the normal functioning of mast cells, which play an important role in immune reactions. Biologist Sara Montagner was able to demonstrate this in her work. She will receive this year's Marie Heim-Vögtlin Prize from the SNSF at the award ceremony in Bellinzona on 29 November 2018. Mast cells are white ...

Schweizerischer Nationalfonds / Fonds national suisse

Melting glaciers have a limited impact on Swiss hydropower production

Bern (ots) - A new study quantifies the effect of glacier retreat due to global warming on hydropower production. This detailed analysis of all Swiss water resources shows that only a small percentage is provided by glacier meltwater. Consequently, the reduction of these waters predicted for the end of the 21st century poses no threat to Swiss hydropower production. ...

Schweizerischer Nationalfonds / Fonds national suisse

Eating less is healthy thanks to gut bacteria

Bern (ots) - Mice with a lower calorie intake live longer and are both healthier and leaner. A team of researchers funded by the SNSF may have found the reason for this positive effect: much of it is down to gut microbial communities and how they affect the immune system. The researchers also found compounds that mimic caloric restriction and may transform obesity treatments. Reducing the intake of calories by up to 40% ...

ECMWF Copernicus Services

ECMWF Copernicus C3S monthly update: Hot and dry weather conditions in July

Reading, England (ots) - July 2018 surface air temperature - Many regions around the globe saw much above average temperatures, due in part to sustained heatwaves, for instance in northern Europe, northern China, Korea and Japan. - Europe saw its second warmest July on record, half a degree cooler than the warmest July (2010), - globally it was the third warmest July, ...

IMI-PainCare

IMI-PainCare: Public-private partnership tackles major challenges in the care of pain patients

Aachen (ots) - To improve the care of patients with acute or chronic pain, a consortium from academia, small and medium-sized enterprises (SMEs), pain societies, patient organizations and pharmaceutical industry launched the research project "IMI-PainCare - Improving the care of patients suffering from acute or ...

Sequana Medical AG

Sequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study

Zurich, SWITZERLAND (ots) - Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of ...

European Society for Medical Oncology (ESMO)

ESMO Publishes New Position Paper on Supportive and Palliative Care

Lugano (ots) - ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care, calling attention to the evolving and growing gap between the needs of cancer patients and the actual provision of patient-centred care. "New studies show that there may be a gap between what doctors think is important for patients, and what patients really need. With this position ...

Debiopharm International SA

GenePOC Launches its new GenePOC(TM) GBS DS test / GenePOC announces the launch of its Group B Streptococcus Direct Swab (DS) molecular test in Europe

Québec, Canada (ots) - GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce the launch of its 2nd assay this year, GenePOC(TM) GBS DS[1], for use on the revogene(TM) instrument. GenePOC GBS DS at intrapartum will aid to minimize the risk of GBS transmission from the mother to their ...

Debiopharm International SA

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2017 JCA-Mauvernay Award

Lausanne (ots) - The 'JCA-Mauvernay Award 2017' is awarded to Doctors Yasuhiro Yamada and Hiroyoshi Nishikawa Debiopharm Group(TM) (Debiopharm - www.debiopharm.com), a Swiss-based global biopharmaceutical company, will be presenting the 'JCA-Mauvernay Award' on September 30 to Doctors Yasuhiro Yamada from the ...

Asate AG

2

Great Honor for Swiss Therapist in America. Snoring and Sleep Apnea Researcher Alex Suarez receives Ig-Nobel Prize

European Society for Medical Oncology (ESMO)

CAREFOR calls on EU to safeguard independent academic research

Debiopharm International SA

Debiopharm International SA Awarded $2.6 Million Grant from CARB-X to Support Development of Debio 1453 to fight drug resistant gonorrhea

Lausanne (ots) - Debiopharm, in collaboration with CARB-X, will utilize their state-of-the-art Fabiotics platform to develop novel therapeutics to combat drug-resistant gonorrhea. Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical ...

Neovii Pharmaceuticals AG

Long-term outcomes after standard graft-versus-host disease (GvHD) prophylaxis in hemopoietic cell transplantation from matched unrelated donors strongly support the use of Grafalon® as standard therapy

Debiopharm International SA

Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor

Craigavon, N.I., UK, Lausanne, Switzerland (ots) - Almac Discovery (www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA (Debiopharm - www.debiopharm.com), a Switzerland based specialty ...

Debiopharm International SA

Debiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284

Lausanne, Switzerland (ots) - Debio 1347/CH5183284 was evaluated in patients with FGFR genomically activated advanced solid tumors Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the results from the phase I ...